Trevena
TRVN
#10609
Rank
ยฃ0 M
Marketcap
ยฃ0.009001
Share price
0.00%
Change (1 day)
-99.32%
Change (1 year)

Operating Margin for Trevena (TRVN)

Operating Margin as of December 2025 (TTM): -5,687.91%

According to Trevena's latest financial reports and stock price the company's current Operating Margin is -5,687.91%. At the end of 2023 the company had an Operating Margin of -1,279.07%.

Operating Margin history for Trevena from 2013 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-1,279.07%-90.04%
2022-12,839.71%41.12%
2021-9,098.41%860.58%
2020-947.18%-98.82%
2019-80,229.03%15209.19%
2018-524.06%
2016-2,746.51%239.73%
2015-808.45%
2013-17,225.84%789.73%
2012-1,936.08%196.52%
2011-652.93%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Amgen
AMGN
22.91%-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-862.21%-84.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-879.80%-84.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-100.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.